The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.
Open accessAbstract
The basic carboxy terminus of p53 plays an important role in directing the protein into the nuclear compartment. The C terminus of the p53 molecule contains a cluster of several nuclear localization signals (NLSs) that mediate the migration of the protein into the cell nucleus. NLSI, the most active domain, is highly conserved in genetically diverged species and shares perfect homology with consensus NLS sequences found in other nuclear proteins. The other two NLSs, II and III, appear to be less effective and less conserved. Although nuclear localization is dictated primarily by the NLSs inherent in the primary amino acid sequence, the actual nuclear homing can be modified by interactions with other proteins expressed in the cell. Comparison between wild-type p53 and naturally occurring mutant p53 showed that both protein categories could migrate into the nucleus of rat primary embryonic fibroblasts by essentially similar mechanisms. Nuclear localization of both proteins was totally dependent on the existence of functional NLS domains. In COS cells, however, we found that NLS-deprived wild-type p53 molecules could migrate into the nucleus by complexing with another nuclear protein, simian virus 40 large-T antigen. Wild-type and mutant p53 proteins differentially complexed with viral or cellular proteins, which may significantly affect the ultimate compartmentalization of p53 in the cell; this finding suggests that the actual subcellular compartmentalization of proteins may differ in various cell type milieux and may largely be affected by the ability of these proteins to complex with other proteins expressed in the cell. Experiments designed to test the physiological significance of p53 subcellular localization indicated that nuclear localization of mutant p53 is essential for this protein to enhance the process of malignant transformation of partially transformed cells, suggesting that p53 functions within the cell nucleus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Kessler, S. W. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.115.6.1617 · Cited by 2,915
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Sequence requirements for nuclear location of simian virus 40 large-T antigen
Kalderon, D., Richardson, W. D., Markham, A. F., & Smith, A. E. (1984) · Nature · doi:10.1038/311033a0 · Cited by 1,286
Cited by
Items 101–200 of 358
Pyrrolidine Dithiocarbamate Prevents p53 Activation and Promotes p53 Cysteine Residue Oxidation
Wu, H., & Momand, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18898 · Cited by 72
Nuclear and nucleolar targeting of human ribosomal protein S6.
Schmidt, C., Lipsius, E., & Kruppa, J. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1875 · Cited by 68
Controlling Protein Compartmentalization to Overcome Disease
Davis, J. R., Kakar, M., & Lim, C. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9133-z · Cited by 65
P53 transcriptional activities: A general overview and some thoughts
Millau, J., Bastien, N., & Drouin, R. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.06.002 · Cited by 83
Cytoplasmic p53 Polypeptide Is Associated with Ribosomes
Fontoura, B. M. A., Atienza, C. A., Sorokina, E. A., Morimoto, T., & Carroll, R. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3146 · Cited by 65
Akakura, S., Yoshida, M., Yoneda, Y., & Horinouchi, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100200200 · Cited by 73
Ronen, D., Rotter, V., & Reisman, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4128 · Cited by 63
Self-citationGenomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia
Chu, L. L., Rutteman, G. R., Kong, J. M. C., Ghahremani, M., Schmeing, M., Misdorp, W., van Garderen, E., & Pelletier, J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006010526813 · Cited by 62
Takahashi, K., & Suzuki, K. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550322 · Cited by 62
Mandić, R., Schamberger, C. J., Müller, J. F., Geyer, M., Zhu, L., Carey, T. E., Grenman, R. A., Dünne, A.-A., & Werner, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0378 · Cited by 60
Thukral, S. K., Blain, G. C., Chang, K. K. H., & Fields, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8315 · Cited by 60
Pohnke, Y., Schneider‐Merck, T., Fahnenstich, J., Kempf, R., Christian, M., Milde‐Langosch, K., Brosens, J. J., & Gellersen, B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0012 · Cited by 59
Liang, S., & Clarke, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202350 · Cited by 59
Nuclear Import and Export Signals in Control of the p53-related Protein p73
Inoue, T. M., Stuart, J., Leno, R., & Maki, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200248200 · Cited by 66
Role of the cytoskeleton in nuclear import
Campbell, E., & Hope, T. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00049-8 · Cited by 66
Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53.
Loging, W., & Reisman, D. (1999) · PubMed · Cited by 58
p53 gene mutation in thyroid carcinoma
Ho, Y.-S., Tseng, S.-C., Chin, T., Hsieh, L.-L., & Lin, J. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04196-1 · Cited by 58
Importin-mediated Nuclear Translocation of Galectin-3
Nakahara, S., Hogan, V. A., Inohara, H., & Raz, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608069200 · Cited by 65
Clabough, E. B. D., & Zeitlin, S. O. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi477 · Cited by 57
Merrick, B. A., He, C., Witcher, L. L., Patterson, R. M., REID, J. J., Pm, P., & Selkirka, J. K. (1996) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(96)00089-1 · Cited by 57
Azar, S., Udi, S., Drori, A., Hadar, R., Nemirovski, A., Vemuri, K. V., Miller, M., Sherill-Rofe, D., Arad, Y., Gur‐Wahnon, D., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101087 · Cited by 56
Nuclear proteins acting on mitochondria
Lindenboim, L., Borner, C., & Stein, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.016 · Cited by 56
RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response
Ozaki, T., Nakagawara, A., & Nagase, H. (2013) · International Journal of Genomics · doi:10.1155/2013/271347 · Cited by 58
Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.
Mayr, G. A., Reed, M. J., Wang, P., Wang, Y., Schweds, J. F., & Tegtmeyer, P. (1995) · PubMed · Cited by 53
Liang, S., Hong, D., & Clarke, M. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19817 · Cited by 59
Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.
Shaulsky, G., Goldfinger, N., Peled, A., & Rotter, V. (1991) · PubMed · Cited by 53
Self-citationIosefson, O., & Azem, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.019 · Cited by 52
Ehp53, an Entamoeba histolytica protein, ancestor of the mammalian tumour suppressor p53
Mendoza, L., Orozco, E., Rodríguez, M. A., García‐Rivera, G., Sánchez, T., García, E. N., & Gariglio, P. (2003) · Microbiology · doi:10.1099/mic.0.25892-0 · Cited by 52
Post-translational regulation of p53 function through 20S proteasome-mediated cleavage
Solomon, H., Bräuning, B., Fainer, I., Ben‐Nissan, G., Rabani, S., Goldfinger, N., Moscovitz, O., Shakked, Z., Rotter, V., & Sharon, M. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.139 · Cited by 50
Self-citationDistal Protein Sequences Can Affect the Function of a Nuclear Localization Signal
Gao, M., & Knipe, D. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1330-1339.1992 · Cited by 50
Cesare, M. D., Cominetti, D., Doldi, V., Lopergolo, A., D, M. D. M., Gandellini, P., Friedlander, S., Landesman, Y., Kauffman, M. G., Shacham, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3761 · Cited by 50
Rodríguez, J. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.005 · Cited by 51
Posttranslational phosphorylation of mutant p53 protein in tumor development
Matsumoto, M., Furihata, M., & Ohtsuki, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0320-0 · Cited by 47
Regulation of p53 in embryonic stem cells
Solozobova, V., & Blattner, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.006 · Cited by 45
Modulation of p53 C-Terminal Acetylation by mdm2, p14ARF, and Cytoplasmic SirT2
van Leeuwen, I. M. M., Higgins, M., Campbell, J., McCarthy, A. R., Sachweh, M. C. C., Navarro, A. M., & Laín, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0904 · Cited by 45
Skiadopoulos, M. H., & McBride, A. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1117-1124.1996 · Cited by 45
p53 Expression in Human Breast Cancer
Harris, A. L. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60303-6 · Cited by 45
Xu, D., Tong, X., Sun, L., Li, H., Jones, R., Liao, J., & Yang, G. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23097 · Cited by 44
Rabban, J. T., Garg, K., Ladwig, N. R., Zaloudek, C. J., & Devine, W. P. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001713 · Cited by 48
Genetic influence on cigarette-induced cardiovascular disease
Wang, X. L., Raveendran, M., & Wang, J. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.11 · Cited by 45
p53 stabilization: the importance of nuclear import
Marine, J. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2009.183 · Cited by 44
Münster, A.-K., Weinhold, B., Gotza, B., Mühlenhoff, M., Frosch, M., & Gerardy‐Schahn, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201093200 · Cited by 41
p53 Isoforms as Cancer Biomarkers and Therapeutic Targets
Zhao, L., & Sanyal, S. (2022) · Cancers · doi:10.3390/cancers14133145 · Cited by 44
Control of p53 nuclear accumulation in stressed cells
Inoue, T. M., Wu, L., Stuart, J., & Maki, C. G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.006 · Cited by 44
Nakamura, Y., Ozaki, T., Niizuma, H., Ohira, M., Kamijo, T., & Nakagawara, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.057 · Cited by 40
Molecular aspects of early stages of breast cancer progression
Smith, H. S., Lü, Y., Deng, G., Martinez, O. M., Krams, S. M., Ljung, B., Thor, A. D., & Lagios, M. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531128 · Cited by 40
Gaynor, K. U., Grigorieva, I. V., Allen, M. D., Esapa, C. T., Head, R. A., Gopinath, P., Christie, P. T., Nesbit, M. A., Jones, J. L., & Thakker, R. V. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0138-x · Cited by 39
Cellular adaptation to hypoxia and p53 transcription regulation
Zhao, Y., Chen, X., & Du, J.-Z. (2009) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b0820293 · Cited by 42
The in Vitro Phosphorylation of P53 by Calcium‐Dependent Protein Kinase C
Delphi, C., Huang, K., Scotto, C., Chapel, A., Vinçon, M., CHAMBAZ, E. M., Garin, J., & Baudier, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00684.x · Cited by 44
Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs, J., Hardman, R. C., Carman, T. A., Barrett, J. C., & Weissman, B. E. (1998) · PubMed · Cited by 39
p53: functions, mutations and sarcomas
Hung, J. Y., & Anderson, R. L. (1997) · Acta Orthopaedica Scandinavica · doi:10.1080/17453674.1997.11744705 · Cited by 39
Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE)
Smith‐Sørensen, B., Gebhardt, M. C., Kloen, P., McIntyre, J., Aguilar, F., Cerutti, P., & Børresen‐Dale, A. (1993) · Human Mutation · doi:10.1002/humu.1380020407 · Cited by 39
Takahashi, K., Sumimoto, H., Suzuki, K., & Ono, T. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080112 · Cited by 39
p53 domains: suppression, transformation, and transactivation.
Reed, M. J., Wang, Y., Mayr, G. A., Me, A., Schwedes, J. F., & Tegtmeyer, P. (1993) · Europe PMC (PubMed Central) · Cited by 38
O’Hagan, H. M., & Ljungman, M. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207709 · Cited by 41
Moll, U. M., Ostermeyer, A. G., Ahomadegbe, J., Mathieu, M., & RIOU, G. F. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90292-9 · Cited by 37
Soussi, T. (1995) · Advances in genome biology · doi:10.1016/s1067-5701(06)80005-7 · Cited by 38
Naito, M. F., Satake, M., Sakai, E., Hirano, Y., Tsuchida, N., Kanzaki, H., Ito, Y., & Mori, T. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02717.x · Cited by 37
Isolation and Characterization of DNA Sequences That Are Specifically Bound by Wild-Type p53 Protein
Foord, O., Navot, N., & Rotter, V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1378 · Cited by 37
Self-citationFarcy, É., Fleury, C., Lelong, C., Dubos, M., Voiseux, C., Fiévet, B., & Lebel, J. (2008) · Marine Environmental Research · doi:10.1016/j.marenvres.2008.04.006 · Cited by 36
Direct Induction of Apoptosis Using an Optimal Mitochondrially Targeted p53
Mossalam, M., Matissek, K. J., Okal, A., Constance, J. E., & Lim, C. S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3000259 · Cited by 36
Weisbrod, A. B., Zhang, L., Jain, M., Barak, S., Quezado, M., & Kebebew, E. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0134-1 · Cited by 36
Cell‐cycle dependent biosynthesis and localization of p53 protein in untransformed human cells
Katsumoto, T., Higaki, K., Ohno, K., & Onodera, K. (1995) · Biology of the Cell · doi:10.1016/0248-4900(96)89426-3 · Cited by 36
Song, X., Sheppard, H. M., Norman, A. W., & Liu, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1677 · Cited by 36
Selter, H., & Montenarh, M. (1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90139-2 · Cited by 41
Antiviral activity of doxycycline against vesicular stomatitis virusin vitro
Wu, Z., Wang, X., Wei, J., Li, B., Shao, D., Li, Y., Liu, K., Shi, Y., Zhou, B., Qiu, Y., et al. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv195 · Cited by 35
Longshaw, V. M., Dirr, H. W., Blatch, G. L., & Lässle, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.139 · Cited by 35
Cytomegalovirus inhibits p53 nuclear localization signal function
Wang, J., Belcher, J. D., Marker, P. H., Wilcken, D. E. L., Vercellotti, G. M., & Wang, X. L. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000157 · Cited by 35
Regulation of the DNA binding of p53 by its interaction with protein kinase CK2
Prowald, A., Schuster, N., & Montenarh, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00399-2 · Cited by 34
Chen, Y., Chen, P., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6764 · Cited by 38
Suwa, H., Yoshimura, T., Yamaguchi, N., Kanehira, K., Manabe, T., Imamura, M., Hiai, H., & Fukumoto, M. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02898.x · Cited by 32
Nuclear translocation of Fos is stimulated by interaction with Jun through the leucine zipper
Chida, K., Nagamori, S., & Kuroki, T. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050291 · Cited by 32
p53 mutations in matched primary and metastatic human tumors
PELLER, S., Halevy, A., SLUTZKI, S., Kopilova, Y., & Rotter, V. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130306 · Cited by 32
Self-citationLi-Fraumeni Syndrome and the Role of the p53 Tumor Suppressor Gene in Cancer Susceptibility
AKASHI, M., & Koeffler, H. P. (1998) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-199803000-00024 · Cited by 31
Landesman, Y., Bringold, F., Milne, D., & Meek, D. W. (1997) · Cellular Signalling · doi:10.1016/s0898-6568(97)89890-7 · Cited by 35
Smoking‐gene Interaction and Disease Development: Relevance to Pancreatic Cancer and Atherosclerosis
Wang, X. L., & Wang, J. (2005) · World Journal of Surgery · doi:10.1007/s00268-004-7819-0 · Cited by 37
p53 Is Associated with the Nuclear Envelope in Mouse Testis
Yin, Y., DeWolf, W. C., & Morgentaler, A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6867 · Cited by 30
Diverse nuclear transport pathways regulate cell proliferation and oncogenesis
Hood, J. K., & Silver, P. A. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00018-4 · Cited by 36
Berge, G., & Mælandsmo, G. M. (2010) · Amino Acids · doi:10.1007/s00726-010-0497-3 · Cited by 32
In search of the functions of normal p53 protein
Rotter, V., Foord, O., & Navot, N. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90151-p · Cited by 29
Self-citationModification of serine 392 is a critical event in the regulation of p53 nuclear export and stability
Kim, Y.-Y., Park, B.-J., Kim, D. J., Kim, W.-H., Kim, S., Oh, K.-S., Lim, J.-Y., Kim, J., Park, C., & Park, S.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.014 · Cited by 27
Stimulation of Polyomavirus DNA Replication by Wild-Type p53 Through the DNA-Binding Site
Kanda, T., Segawa, K., Ohuchi, N., Mori, S., & Ito, Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2651 · Cited by 27
Subekti, D. R. G., Murata, A., Itoh, Y., Fukuchi, S., Takahashi, H., Kanbayashi, S., Takahashi, S., & Kamagata, K. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00292 · Cited by 40
Marks, J. R., Davidoff, A. M., & Iglehart, J. D. (1995) · Humana Press eBooks · doi:10.1007/978-1-4757-2381-6_4 · Cited by 26
Genetic analysis of p53 nuclear importation
Li, Q., Falsey, R. R., Gaitonde, S., Sotello, V., Kislin, K. L., & Martinez, J. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210597 · Cited by 26
Akgũl, B., Karle, P., Adam, M., Fuchs, P. G., & Pfister, H. (2003) · Virology · doi:10.1016/s0042-6822(02)00133-2 · Cited by 26
p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos
Schneider, B., Pekkel, V., Shelton, C. H., Pulitzer, D. R., Allred, D. C., Hilsenbeck, S. G., Hensel, C. H., Rodr�guez-Mart�nez, H. A., & C., M. E. G.-D. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00193499 · Cited by 26
p53 Expression in Incidental Prostatic Cancer
Veldhuizen, P. J. V., Sadasivan, R., Cherian, R., Dwyer, T., & Stephens, R. L. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199305000-00001 · Cited by 26
Wappenschmidt, B., Hauke, J., Faust, U., Niederacher, D., Wiesmüller, L., Schmidt, G., Groß, E., Gehrig, A., Sutter, C., Ramser, J., et al. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1110-0909 · Cited by 25
Tatematsu, K., Yoshimoto, N., Koyanagi, T., Tokunaga, C., Tachibana, T., Yoneda, Y., Yoshida, M., Okajima, T., Tanizawa, K., & Kuroda, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413476200 · Cited by 28
The characterisation of p53 binding phage isolated from phage peptide display libraries
Daniels, D. A., & Lane, D. P. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90038-8 · Cited by 25
Komlódi-Pásztor, E., Trostel, S. Y., Sackett, D. L., Poruchynsky, M. S., & Fojo, T. (2009) · Oncogene · doi:10.1038/onc.2009.166 · Cited by 25
Zhang, R., & Misra, V. (2013) · Cell Cycle · doi:10.4161/cc.27053 · Cited by 24
Conformational phenotype of p53 is linked to nuclear translocation
Gaitonde, S., Riley, J. R., Qiao, D., & Martinez, J. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203756 · Cited by 24
Hsf1 Is Required for the Nuclear Translocation of p53 Tumor Suppressor
Li, Q., Feldman, R. A., Radhakrishnan, V. M., Carey, S. S., & Martinez, J. D. (2008) · Neoplasia · doi:10.1593/neo.08430 · Cited by 27
Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra, A. P., Lin, H. C., Côté, R. J., & Datar, R. H. (2005) · PubMed · Cited by 23
A non-random deletion in the p53 gene in oral squamous cell carcinoma
Nylander, K., SCHILDT, E. ‐., Eriksson, M., Magnusson, A., Mehle, C., & Roos, G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.262 · Cited by 23
Zhang, T., Birbrair, A., & Delbono, O. (2013) · Cytoskeleton · doi:10.1002/cm.21095 · Cited by 22
Gu, J., Kawai, H., Wiederschain, D., & Yuan, Z.-M. (2001) · PubMed · Cited by 22
Miyaki, M., Iijima, T., Yasuno, M., Kita, Y., Hishima, T., Kuroki, T., & Mori, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205887 · Cited by 21
Metadata
- Authors
- Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V
- Affiliations
- Weizmann Institute of Science (IL)
- ORCID
- Shaulsky, G
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-12
- Volume
- 10
- Issue
- 12
- Pages
- 6565-6577
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC362933
- OpenAlex
- W1806610286
- Cited by
- 356
- References
- 60
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 10 · 2013: 11 · 2012: 5
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Princeton University
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- p53, nuclear localization signal, nuclear accumulation, p53 C-terminal domain, SV40 large T antigen, protein-protein interaction, subcellular localization, carcinogenesis, malignant transformation, mutant p53, embryonic fibroblasts
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosome Deletion, Cloning, Molecular, Humans, Molecular Sequence Data, Plasmids, Sequence Homology, Nucleic Acid, Transfection, Signal Transduction, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.